OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
59
Results
Show all
Save search
Copy query
Show results for
Unknown
(59)
Publication Date
Release Date
2018
(8)
2017
(8)
2019
(7)
2021
(6)
2024
(4)
2010
(4)
2023
(3)
2022
(3)
2020
(3)
2016
(3)
2015
(3)
2014
(2)
2011
(2)
2026
(1)
2025
(1)
2012
(1)
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105.
Not available
S-EPMC4451172
|
biostudies-literature
Cite
Cetuximab Plus Chemoradiotherapy for HIV-Associated Anal Carcinoma: A Phase II AIDS Malignancy Consortium Trial.
Not available
S-EPMC5455422
|
biostudies-literature
Cite
Surgical Excision Without Radiation for Ductal Carcinoma in Situ of the Breast: 12-Year Results From the ECOG-ACRIN E5194 Study.
Not available
S-EPMC4652014
|
biostudies-literature
Cite
Cetuximab Plus Chemoradiotherapy in Immunocompetent Patients With Anal Carcinoma: A Phase II Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group Trial (E3205).
Not available
S-EPMC5455423
|
biostudies-literature
Cite
Double-Blind Phase III Trial of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer (E5103).
Not available
S-EPMC6118403
|
biostudies-literature
Cite
Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.
Not available
S-EPMC4162494
|
biostudies-literature
Cite
EIF2C is overexpressed and amplified in head and neck squamous cell carcinoma.
Not available
S-EPMC2975733
|
biostudies-literature
Cite
Combination antiretroviral therapy accelerates immune recovery in patients with HIV-related lymphoma treated with EPOCH: a comparison within one prospective trial AMC034.
Not available
S-EPMC5962410
|
biostudies-literature
Cite
A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.
Not available
S-EPMC10792358
|
biostudies-literature
Cite
The 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysis.
Not available
S-EPMC8758772
|
biostudies-literature
Cite
Previous
page
1 / 6
You're on page
1
page
2
page
3
page
4
page
5
page
6
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets